Jung, T.; Haist, M.; Kuske, M.; Grabbe, S.; Bros, M.
Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy—Paradoxical ERK Activation and Beyond. Int. J. Mol. Sci. 2021, 22, 9890.
https://doi.org/10.3390/ijms22189890
AMA Style
Jung T, Haist M, Kuske M, Grabbe S, Bros M.
Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy—Paradoxical ERK Activation and Beyond. International Journal of Molecular Sciences. 2021; 22(18):9890.
https://doi.org/10.3390/ijms22189890
Chicago/Turabian Style
Jung, Thomas, Maximilian Haist, Michael Kuske, Stephan Grabbe, and Matthias Bros.
2021. "Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy—Paradoxical ERK Activation and Beyond" International Journal of Molecular Sciences 22, no. 18: 9890.
https://doi.org/10.3390/ijms22189890
APA Style
Jung, T., Haist, M., Kuske, M., Grabbe, S., & Bros, M.
(2021). Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy—Paradoxical ERK Activation and Beyond. International Journal of Molecular Sciences, 22(18), 9890.
https://doi.org/10.3390/ijms22189890